首页 | 本学科首页   官方微博 | 高级检索  
     


Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration‐resistant prostate cancer patients; a possible time relation
Authors:Sushil K. Badrising  Vincent van der Noort  Alfons J.M. van den Eertwegh  Paul Hamberg  Inge M. van Oort  Hendrik P. van den Berg  Maartje Los  Maureen J.B. Aarts  Jules L.L.M. Coenen  Hans Gelderblom  Igle J. de Jong  Emile D. Kerver  Suzan Vrijaldenhoven  Theo van Voorthuizen  Fabienne Warmerdam  John B. Haanen  Andries M. Bergman  On behalf of the Dutch Uro‐Oncology Studygroup
Affiliation:1. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands;2. Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands;3. Department of Oncology, VU University Medical Center, Amsterdam, the Netherlands;4. Department of Oncology & Prostate Cancer Center, Sint Franciscus Gasthuis, Rotterdam, the Netherlands;5. Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands;6. Department of Oncology Tergooi Ziekenhuizen, Blaricum, the Netherlands;7. Department of Oncology, Sint Antonius Hospital, Nieuwegein, the Netherlands;8. Department of Medical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands;9. Department of Oncology, Isala Klinieken, Zwolle, the Netherlands;10. Department of Clinical Oncology, Leiden University Medical Center, the Netherlands;11. Department of Urology, University of Groningen, Groningen, the Netherlands;12. Department of Oncology, OLVG Hospital, Amsterdam, the Netherlands;13. Department of Internal Medicine, Medisch Centrum Alkmaar, Alkmaar, the Netherlands;14. Department of Oncology, Rijnstate Hospital, Arnhem, the Netherlands;15. Department of Internal Medicine/Oncology, Atrium‐Orbis Medical Center, Heerlen, the Netherlands
Abstract:
Keywords:prostate cancer  enzalutamide  abiraterone  docetaxel  cross‐resistance  AR plasticity
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号